Beta1 integrin expression by podocytes is required to maintain glomerular structural integrity
- PMID: 18328474
- PMCID: PMC2396524
- DOI: 10.1016/j.ydbio.2008.01.022
Beta1 integrin expression by podocytes is required to maintain glomerular structural integrity
Abstract
Integrins are transmembrane heteromeric receptors that mediate interactions between cells and extracellular matrix (ECM). beta1, the most abundantly expressed integrin subunit, binds at least 12 alpha subunits. beta1 containing integrins are highly expressed in the glomerulus of the kidney; however their role in glomerular morphogenesis and maintenance of glomerular filtration barrier integrity is poorly understood. To study these questions we selectively deleted beta1 integrin in the podocyte by crossing beta1(flox/flox) mice with podocyte specific podocin-cre mice (pod-Cre), which express cre at the time of glomerular capillary formation. We demonstrate that podocyte abnormalities are visualized during glomerulogenesis of the pod-Cre;beta1(flox/flox) mice and proteinuria is present at birth, despite a grossly normal glomerular basement membrane. Following the advent of glomerular filtration there is progressive podocyte loss and the mice develop capillary loop and mesangium degeneration with little evidence of glomerulosclerosis. By 3 weeks of age the mice develop severe end stage renal failure characterized by both tubulointerstitial and glomerular pathology. Thus, expression of beta1 containing integrins by the podocyte is critical for maintaining the structural integrity of the glomerulus.
Figures
References
-
- Aumailley M, et al. A simplified laminin nomenclature. Matrix Biol. 2005;24:326–332. - PubMed
-
- Bjarnegard M, et al. Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development. 2004;131:1847–57. - PubMed
-
- Borza CM, et al. Integrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3. J Biol Chem. 2006;281:20932–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P01 DK065123/DK/NIDDK NIH HHS/United States
- P50 DK039261/DK/NIDDK NIH HHS/United States
- R01-DK74359/DK/NIDDK NIH HHS/United States
- R01-DK064687/DK/NIDDK NIH HHS/United States
- R01 DK064687/DK/NIDDK NIH HHS/United States
- P01 DK65123/DK/NIDDK NIH HHS/United States
- R01 DK051265/DK/NIDDK NIH HHS/United States
- P50-DK39261-16/DK/NIDDK NIH HHS/United States
- R01-DK69921/DK/NIDDK NIH HHS/United States
- R01-CA94849/CA/NCI NIH HHS/United States
- R01-DK51265/DK/NIDDK NIH HHS/United States
- R01 CA094849/CA/NCI NIH HHS/United States
- R01 DK069921/DK/NIDDK NIH HHS/United States
- R01 DK075594/DK/NIDDK NIH HHS/United States
- R01 DK074359/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
